BUZZ-OncoSec公司因与美国FDA就癌症治疗进行积极会谈而上涨

Reuters
May 17, 2023

** 癌症药物开发商OncoSec Medical Inc 股价上涨18.6%至0.97美元

** 公司说 (link),它与美国食品和药物管理局会面,讨论中期研究设计,以测试其实验性组合疗法,治疗一种可通过手术切除的皮肤癌。

** 公司的实验性疗法与默克公司的 Keytruda相结合,将作为新辅助性免疫疗法进行测试

**新辅助免疫疗法是在手术前作为第一步来缩小肿瘤。

** 该组合疗法早些时候在测试晚期不可切除皮肤癌的中期研究中未能达到主要目标, (link)。

** 包括盘中涨幅在内,该股今年以来下跌约43%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10